Market Quick Take - 12 May 2025

Market Quick Take - 12 May 2025

Macro 3 minutes to read
Saxo Strategy Team

Note: This is marketing material.

Market Quick Take – 12 May 2025


Market drivers and catalysts

  • Equities: US-China trade optimism; European markets poised higher; Asian markets broadly positive; pharma under pressure
  • Volatility: Significant decline in VIX futures; markets calmer ahead of key US economic data
  • Digital assets: Bitcoin stable; crypto response muted; select crypto stocks outperforming
  • Fixed Income: Mild sell-off in US treasuring on the US-China trade talk news
  • Currencies: USD firmed sharply on positive US-China trade talk spin, but strength later faded
  • Commodities: Trade talks lift energy and industrial metals as gold slumps
  • Macro events: US Federal Budget Balance, Australia Consumer and Business Confidence


Macro data and headlines

  • The US and China claimed “substantial progress” in trade talks carried out in Switzerland over the weekend. China’s chief negotiatsor, Vice Premier He Lifeng, called the talks an “important first step”. Very few specifics are available on what was agreed, but He said that a mechanism for further talks was agreed, which on the US side would be led by Treasury Secretary Scott Bessent.
  • A joint US-China statement with further details on trade talks is expected some time today.
  • US President Trump claimed that he could lower drug prices in the US by 30% to 80% by requiring that the US pay the same price for drugs as the countries that pay the lowest price for the drug elsewhere in the world.
  • Ukrainian president Zelenskyy offered to meet Russian President Putin in person later this week in Istanbul for trade talks.
  • Japan is taking a stand on US auto tariffs, as Prime Minister Ishiba said that the country won’t agree to any trade agreement with the US that excludes an agreement on autos. Japan’s lead trade negotiator Ryosei Akazawa said he hopes that the two sides can move to an agreement in June.


Macro calendar highlights (times in GMT)

1800 – US Apr. Federal Budget Balance
0030 – Australia May Westpac Consumer Confidence
0130 – Australia Apr. NAB Business Confidence

Earnings events

  • Monday: Constellation Software
  • Tuesday: Softbank, Nu Holdings
  • Wednesday: Tencent, Cisco Systems, Sony
  • Thursday: Walmart, Deutsche Telekom, Allianz, Mitsubishi Financial, Deere, Applied Materials
  • Friday: Richemont

For all macro, earnings, and dividend events check Saxo’s calendar.


Equities

  • US: US stock futures surged sharply Monday following positive developments from US-China trade talks in Geneva. Futures for the Dow and S&P 500 gained over 1%, and Nasdaq 100 futures rose nearly 2%. Treasury Secretary Scott Bessent described the talks as "productive," fueling optimism despite continued uncertainty about broader tariff policies. Investors are closely watching key economic data this week, particularly consumer inflation figures Tuesday and retail sales Thursday, to gauge the impact of recent trade tensions. Last Friday, the S&P 500 closed slightly lower (-0.07%).
  • Europe: European equities are set for strong gains Monday, buoyed by easing US-China trade tensions. Euro Stoxx 50 and Stoxx 600 futures rose 1% and 0.8%, respectively. Last Friday, European indices closed higher on optimism surrounding the trade talks, with STOXX 50 up 0.4%, and Germany’s DAX and France’s CAC gaining 0.63% and 0.64%, respectively. Financials like Mediobanca and consumer discretionary stocks such as BMW and LVMH were top performers, reflecting positive investor sentiment ahead of key earnings from UniCredit today.
  • UK: UK stocks are anticipated to open higher Monday, tracking global optimism. FTSE 100 futures increased by 0.3%. Key news includes Banco Santander rejecting an £11 billion bid from NatWest for its UK retail operations. Oil prices firmed amid US-China optimism, while gold retreated as safe-haven demand declined. Last Friday, the FTSE 100 gained 0.27%, supported by strong earnings from British Airways owner IAG (+2.38%) and upbeat corporate developments.
  • Asia: Asian markets rallied Monday as US-China trade negotiations concluded positively. Hong Kong’s Hang Seng jumped 1.4%, marking its eighth consecutive gain. China's CSI 300 and Shanghai Composite added about 1.1% and 0.9%, respectively. India's Nifty soared nearly 3% after a US-brokered ceasefire with Pakistan held firm. However, pharmaceutical stocks dropped after President Trump announced plans to cut drug prices significantly, impacting key regional pharma companies negatively.

Volatility

Volatility eased significantly with positive US-China trade developments. VIX futures declined sharply (-5.45%), reflecting reduced market anxiety. On Friday, the VIX closed at 21.90, slightly lower amid declining uncertainty. Investors remain cautious, however, preparing for key economic data this week, especially the US CPI release tomorrow. Earnings from Walmart will also provide insights into the retail sector, potentially influencing volatility further.


Digital Assets

Crypto markets displayed muted reactions despite significant trade optimism, with Bitcoin barely positive at $104,333 (+0.20%) and Ether slightly negative at $2,511 (-0.13%). The subdued crypto response contrasts with equities' bullishness, suggesting traders seek more concrete details from the US-China negotiations. However, select crypto-related stocks performed strongly, notably Marathon Digital (+10.29%) and CleanSpark (+5.99%), signaling continued speculative appetite.
 

Fixed Income

  • US treasury yields rose on the friendly tone of statements emerging from the US-China trade talks, with the US 10-year benchmark yield a couple of basis points above Friday’s close, trading near 4.4% late in the Asian session on Monday, while the 2-year benchmark likewise up at multi-week highs slightly above Friday’s close, trading just above 3.90%.
  • US high-yield corporate credit spreads were little changed Friday, with the Bloomberg High Yield spread to US treasuries indicator we track widening a single basis point to 343 basis points on Friday.


Commodities

  • Gold trades sharply lower with US-China trade progress lifting both the US dollar and US Treasury yields, while a ceasefire between Pakistan and India seems to be holding, and Ukraine challenging Putin to engage in talks this week. Hedge funds cut their COMEX futures long to a fresh 14-month low last week, highlighting the need for Asian demand to avoid a bigger correction, with focus once again on USD 3,200.
  • Pro-cyclical commodities like crude oil and copper, but also silver and platinum, trade firmer with sentiment boosted by the trade talks between the world’s top two economies, potentially lowering the economic fallout from the current trade war.
  • Soybeans, the hardest-hit crop in the US-China standoff, trade higher while corn and wheat continue to lose ground amid weak exports and favourable planting conditions across the US Plains. In addition, an expanded Brazil soybean acreage and upcoming corn harvest keep the upside limited for now.


Currencies

  • The US dollar firmed sharply as both sides in the US-China trade talks claimed progress, with EURUSD retesting the 1.1200 support and USDJPY lifting back to the recent highs above 146.00 before the USD rally faded again slightly. USDCNH dropped back toward 7.22 after a Friday high above 7.25.
  • Key data from the US this week includes the April CPI report up tomorrow and the April Retail Sales report on Thursday.

For a global look at markets – go to Inspiration.

Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.